🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/11/2017 | 125,30 | 127,25 | 123,95 | 126,20 | +2,58% | 2,63% | 548.700 |
| 17/11/2017 | 121,60 | 123,38 | 120,50 | 123,02 | +1,15% | 2,37% | 297.600 |
| 16/11/2017 | 120,82 | 122,23 | 118,75 | 121,62 | +1,16% | 2,88% | 373.300 |
| 15/11/2017 | 118,09 | 120,86 | 117,43 | 120,22 | +1,38% | 2,90% | 381.000 |
| 14/11/2017 | 119,11 | 120,07 | 117,01 | 118,58 | -0,98% | 2,57% | 312.300 |
| 13/11/2017 | 120,24 | 121,20 | 119,20 | 119,75 | -1,03% | 1,66% | 244.300 |
| 10/11/2017 | 120,59 | 121,27 | 118,79 | 121,00 | -0,19% | 2,06% | 190.600 |
| 09/11/2017 | 123,68 | 123,68 | 120,24 | 121,23 | -1,80% | 2,78% | 303.600 |
| 08/11/2017 | 122,01 | 123,78 | 122,01 | 123,45 | +0,94% | 1,45% | 361.700 |
| 07/11/2017 | 122,39 | 122,92 | 121,30 | 122,30 | +0,24% | 1,32% | 377.000 |
| 06/11/2017 | 121,46 | 122,51 | 120,50 | 122,01 | +0,88% | 1,65% | 363.100 |
| 03/11/2017 | 118,37 | 121,19 | 118,37 | 120,95 | +1,72% | 2,38% | 319.100 |
| 02/11/2017 | 120,60 | 120,93 | 117,08 | 118,90 | -1,09% | 3,19% | 422.400 |
| 01/11/2017 | 119,09 | 121,07 | 118,50 | 120,21 | +1,37% | 2,16% | 469.200 |
| 31/10/2017 | 120,51 | 120,70 | 118,37 | 118,59 | -1,06% | 1,93% | 304.000 |
| 30/10/2017 | 120,05 | 121,86 | 119,23 | 119,86 | -0,16% | 2,19% | 302.500 |
| 27/10/2017 | 119,89 | 121,00 | 115,79 | 120,05 | +0,80% | 4,35% | 462.600 |
| 26/10/2017 | 121,80 | 123,25 | 118,52 | 119,10 | -3,08% | 3,88% | 494.400 |
| 25/10/2017 | 126,58 | 130,69 | 120,73 | 122,89 | +3,36% | 7,87% | 1.089.200 |
| 24/10/2017 | 122,08 | 122,31 | 118,59 | 118,90 | -1,92% | 3,05% | 513.200 |
| 23/10/2017 | 121,16 | 122,06 | 119,70 | 121,23 | +0,18% | 1,95% | 562.300 |
| 20/10/2017 | 119,71 | 121,46 | 118,65 | 121,01 | +1,64% | 2,35% | 402.300 |
| 19/10/2017 | 120,15 | 120,15 | 118,00 | 119,06 | -0,88% | 1,79% | 432.400 |
| 18/10/2017 | 121,62 | 123,15 | 119,81 | 120,12 | -1,37% | 2,75% | 367.800 |
| 17/10/2017 | 119,49 | 123,22 | 119,49 | 121,79 | +1,68% | 3,12% | 237.600 |
| 16/10/2017 | 121,00 | 122,06 | 119,24 | 119,78 | -0,61% | 2,33% | 301.800 |
| 13/10/2017 | 120,56 | 121,88 | 120,20 | 120,51 | +0,20% | 1,39% | 166.700 |
| 12/10/2017 | 120,11 | 121,02 | 119,53 | 120,27 | +0,10% | 1,24% | 256.900 |
| 11/10/2017 | 121,71 | 121,71 | 118,77 | 120,15 | -1,13% | 2,42% | 672.900 |
| 10/10/2017 | 122,25 | 123,35 | 121,40 | 121,52 | -0,43% | 1,60% | 279.100 |